Ruxolitinib and Impurities
Ruxolitinib
CAS:941678-49-5
Ruxolitinib (INCB018424) is a JAK1/2 inhibitor (IC50=3.3/2.8 nM) that is potent and selective.
Formula:
C17H18N6
Purity:
100% - 99.93%
Color and Shape:
Solid
Molecular weight:
306.36
Ref: TM-T1829
5mg | 50.00 € | ||
10mg | 59.00 € | ||
25mg | 80.00 € | ||
50mg | 91.00 € | ||
100mg | 121.00 € | ||
200mg | 192.00 € | ||
500mg | 325.00 € | ||
1mL*10mM (DMSO) | 51.00 € |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093055
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093018
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093039
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093004
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093049
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093030
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093027
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ruxolitinib phosphate
CAS:1092939-17-7
Ruxolitinib phosphate (INCB18424 phosphate) is a JAK1/2 inhibitor with IC50 of 3.3 nM/2.8 nM. Cost-effective …
Formula:
C17H21N6O4P
Purity:
100% - 99.91%
Color and Shape:
Solid
Molecular weight:
404.36
Ref: TM-T3043
1g | 604.00 € | ||
5mg | 52.00 € | ||
10mg | 64.00 € | ||
25mg | 81.00 € | ||
50mg | 95.00 € | ||
100mg | 144.00 € | ||
200mg | 223.00 € | ||
500mg | 408.00 € | ||
1mL*10mM (DMSO) | 59.00 € |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093029
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093020
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093050
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093046
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ruxolitinib Impurity 26 (+)-Dibenzoyltartaric Acid Salt
CAS:2920037-87-0
Formula:
C23H32N6OSi·C18H14O8
Molecular weight:
436.64 358.30
Ref: 4Z-R-093042
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093035
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093031
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093019
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093022
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093053
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-R-093047
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024